FI104717B - Menetelmä terapeuttisesti aktiivisten substituoitujen fenoksi-imidatsoliini- ja fenoksi-tetrahydropyrimidiiniyhdisteiden valmistamiseksi - Google Patents
Menetelmä terapeuttisesti aktiivisten substituoitujen fenoksi-imidatsoliini- ja fenoksi-tetrahydropyrimidiiniyhdisteiden valmistamiseksi Download PDFInfo
- Publication number
- FI104717B FI104717B FI905168A FI905168A FI104717B FI 104717 B FI104717 B FI 104717B FI 905168 A FI905168 A FI 905168A FI 905168 A FI905168 A FI 905168A FI 104717 B FI104717 B FI 104717B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- phenoxy
- med
- substituted
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42442989A | 1989-10-20 | 1989-10-20 | |
| US42442989 | 1989-10-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI905168A0 FI905168A0 (fi) | 1990-10-19 |
| FI104717B true FI104717B (fi) | 2000-03-31 |
Family
ID=23682608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI905168A FI104717B (fi) | 1989-10-20 | 1990-10-19 | Menetelmä terapeuttisesti aktiivisten substituoitujen fenoksi-imidatsoliini- ja fenoksi-tetrahydropyrimidiiniyhdisteiden valmistamiseksi |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0423802B1 (de) |
| JP (1) | JP3097696B2 (de) |
| KR (1) | KR0182808B1 (de) |
| CN (1) | CN1028099C (de) |
| AR (1) | AR248400A1 (de) |
| AT (1) | ATE126217T1 (de) |
| AU (1) | AU627627B2 (de) |
| CA (1) | CA2027530C (de) |
| DE (1) | DE69021490T2 (de) |
| DK (1) | DK0423802T3 (de) |
| ES (1) | ES2088936T3 (de) |
| FI (1) | FI104717B (de) |
| GR (1) | GR3017775T3 (de) |
| HU (1) | HU207300B (de) |
| IE (1) | IE67049B1 (de) |
| IL (1) | IL96064A (de) |
| NO (1) | NO179367C (de) |
| NZ (1) | NZ235688A (de) |
| PH (1) | PH27290A (de) |
| PT (1) | PT95637B (de) |
| ZA (1) | ZA908234B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2156868T3 (es) * | 1992-02-06 | 2001-08-01 | Merrell Pharma Inc | Compuestos de arilalcoxifenoxi-imidazolina. |
| KR100693139B1 (ko) * | 2001-04-19 | 2007-03-13 | 엘지전자 주식회사 | 디스크 드라이브의 트레이 진동방지구조 |
| KR100482010B1 (ko) | 2002-11-05 | 2005-04-14 | 삼성전자주식회사 | 모니터장치 |
| EP1958507A1 (de) | 2007-02-15 | 2008-08-20 | Syngeta Participations AG | Chemische Verbindungen |
| MX2009013742A (es) * | 2007-07-02 | 2010-01-26 | Hoffmann La Roche | 2-imidazolinas. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE614596C (de) * | 1931-07-10 | 1935-06-13 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von ?-Glyoxalidinarylmethylolen |
| US2893993A (en) * | 1958-06-17 | 1959-07-07 | Searle & Co | 2-aryloxyaralkyl-1, 4, 5, 6-tetrahydropyrimidines |
| US3897431A (en) * | 1969-04-24 | 1975-07-29 | Sterling Drug Inc | 2-{8 {60 -Alkoxy-arylmethyl{9 -2-imidazolines and -1,4,5,6-tetrahydropyrimidines |
| AU3546478A (en) * | 1977-04-29 | 1979-11-01 | Ciba Geigy Ag | Ectoparasiticides |
| DE2961710D1 (en) * | 1978-10-09 | 1982-02-18 | Ciba Geigy Ag | 2-(alpha-phenoxy-alkyl)-imidazolines and their salts, their preparation and use, and agents against phytoparasitic and zooparasitic mites containing them |
| US4260626A (en) * | 1979-03-26 | 1981-04-07 | Richardson-Merrell Inc. | Tetrahydro and imidazoline antisecretory compounds |
| IT1231237B (it) * | 1987-09-21 | 1991-11-26 | Angeli Inst Spa | Derivati eterociclici |
-
1990
- 1990-10-12 CA CA002027530A patent/CA2027530C/en not_active Expired - Lifetime
- 1990-10-15 AU AU64565/90A patent/AU627627B2/en not_active Ceased
- 1990-10-15 ZA ZA908234A patent/ZA908234B/xx unknown
- 1990-10-15 NZ NZ235688A patent/NZ235688A/en unknown
- 1990-10-17 PH PH41397A patent/PH27290A/en unknown
- 1990-10-17 AR AR90318103A patent/AR248400A1/es active
- 1990-10-18 KR KR1019900016591A patent/KR0182808B1/ko not_active IP Right Cessation
- 1990-10-19 NO NO904535A patent/NO179367C/no not_active IP Right Cessation
- 1990-10-19 JP JP02279518A patent/JP3097696B2/ja not_active Expired - Lifetime
- 1990-10-19 DK DK90120052.7T patent/DK0423802T3/da active
- 1990-10-19 DE DE69021490T patent/DE69021490T2/de not_active Expired - Lifetime
- 1990-10-19 CN CN90108492A patent/CN1028099C/zh not_active Expired - Lifetime
- 1990-10-19 AT AT90120052T patent/ATE126217T1/de not_active IP Right Cessation
- 1990-10-19 ES ES90120052T patent/ES2088936T3/es not_active Expired - Lifetime
- 1990-10-19 FI FI905168A patent/FI104717B/fi not_active IP Right Cessation
- 1990-10-19 IL IL9606490A patent/IL96064A/en not_active IP Right Cessation
- 1990-10-19 IE IE376590A patent/IE67049B1/en not_active IP Right Cessation
- 1990-10-19 HU HU906514A patent/HU207300B/hu not_active IP Right Cessation
- 1990-10-19 EP EP90120052A patent/EP0423802B1/de not_active Expired - Lifetime
- 1990-10-19 PT PT95637A patent/PT95637B/pt not_active IP Right Cessation
-
1995
- 1995-10-18 GR GR950402877T patent/GR3017775T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI84353B (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva aminoalkoxifenylsubstituerade indolizinderivat. | |
| EP0478954B1 (de) | Serotonin 5HT1A und 5HT1D Agonisten | |
| EP1339679B1 (de) | 3-arylindolderivate und deren verwendung als cb2-rezeptoragonisten | |
| CZ397598A3 (cs) | Derivát 5-fenoxyalkyl-2,4-thiazolidindionu, způsob jeho přípravy, meziprodukty pro jeho přípravu a farmaceutický prostředek, který ho obsahuje | |
| IE51179B1 (en) | Pyridoxine derivatives,process for preparing them and use in therapeutics | |
| SE465928B (sv) | 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition | |
| FI104717B (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen fenoksi-imidatsoliini- ja fenoksi-tetrahydropyrimidiiniyhdisteiden valmistamiseksi | |
| FR2680172A1 (fr) | Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique. | |
| EP0256888B1 (de) | Benzothiazepin-Vasodilatoren mit Aralkylsubstitution | |
| US6358993B1 (en) | Pharmaceutically active nitrogen ring compounds and methods of use thereof | |
| US5134154A (en) | Phenoxy-heterocyclic compounds | |
| FI86301B (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara naftoxaziner. | |
| WO2012081570A1 (ja) | ラクタム化合物又はその塩及びｐｐａｒ活性化剤 | |
| BE883856A (fr) | Nouvelles aroyl-4 amidazolones-2 utiles comme medicaments leur procede de preparation et compositions therapeutiques les contenant | |
| US4663319A (en) | 3-(1,3-dithiol-2-ylidene)-2,4-dioxopyrrolidines, -piperidines, and -hexahydroazepines and use thereof against hepatic diseases | |
| JP2021104931A (ja) | 含窒素複素環を有するジベンゾアゼピン誘導体 | |
| US5407954A (en) | Arylalkoxyphenoxy-imidazoline compounds | |
| US5216008A (en) | Arylalkoxyphenoxy-imidazoline compounds | |
| AU650026B2 (en) | Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof | |
| JPH07238066A (ja) | ベンゼンスルホン酸誘導体、その製造法およびその用途 | |
| Ohnuma et al. | S1P 3 receptor antagonist | |
| HU182717B (en) | Process for preparing 2-/4-hydroxy-alkyl-1-piperazinyl/-2,4,6-cycloheptatrien-1-one derivatives and pharmaceutical compositions containing such compounds as active substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |